Published in J Cancer Res Clin Oncol on March 18, 2003
Challenges to diagnosing colorectal cancer during pregnancy. Can Fam Physician (2009) 0.99
A favorable maternal and neonatal outcome following chemotherapy with etoposide, bleomycin, and cisplatin for management of grade 3 immature teratoma of the ovary. J Gynecol Oncol (2009) 0.83
The treatment of hematologic malignancies in pregnancy. Facts Views Vis Obgyn (2010) 0.81
Prognosis of thyroid cancer related to pregnancy: a systematic review. J Thyroid Res (2011) 0.79
Meanings of abortion in context: accounts of abortion in the lives of women diagnosed with breast cancer. BMC Womens Health (2017) 0.75
Management of Concurrent Pregnancy and Acute Lymphoblastic Malignancy in Teenaged Patients: Two Illustrative Cases and Review of the Literature. J Adolesc Young Adult Oncol (2014) 0.75
Therapeutic Difficulty in a Case of Supratentorial Primitive Neuroectodermal Tumor Diagnosed during Pregnancy. J Korean Neurosurg Soc (2009) 0.75
Management of metastatic thyroid cancer in pregnancy: risk and uncertainty. Endocrinol Diabetes Metab Case Rep (2016) 0.75
Metastatic melanoma positively influences pregnancy outcome in a mouse model: could a deadly tumor support embryo life? Clin Exp Metastasis (2007) 0.75
CARCINOMA OF THE BREAST: II. CRITERIA OF OPERABILITY. Ann Surg (1943) 6.42
Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood (1988) 6.09
All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood (1990) 4.36
Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). N Engl J Med (1991) 3.52
The "retinoic acid syndrome" in acute promyelocytic leukemia. Ann Intern Med (1992) 2.99
Does pregnancy protect against ovarian cancer? Lancet (1978) 2.28
Medical progress. Congenital malformations: etiologic factors and their role in prevention (first of two parts). N Engl J Med (1983) 2.01
Surgical management of cervical cancer complicating pregnancy: a case-control study. Gynecol Oncol (1996) 1.87
Malignant melanoma and oral contraceptive use among women in California. Br J Cancer (1977) 1.76
Interferon-alpha therapy during pregnancy in chronic myelogenous leukaemia and hairy cell leukaemia. Br J Haematol (1992) 1.75
Use of hydroxyurea in chronic myeloid leukemia during pregnancy: a case report. Am J Obstet Gynecol (1991) 1.73
Determinants of papillary cancer of the thyroid. Am J Epidemiol (1993) 1.64
The natural history of untreated acute leukemia. Ann N Y Acad Sci (1954) 1.54
The effect of embryonic and fetal exposure to x-ray, microwaves, and ultrasound: counseling the pregnant and nonpregnant patient about these risks. Semin Oncol (1989) 1.49
Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero. Clin Lymphoma (2001) 1.47
Malignant melanoma and pregnancy. Cancer (1985) 1.47
Pregnancy in association with a newly diagnosed cancer: a population-based epidemiologic assessment. Int J Cancer (1984) 1.42
Pregnancy-associated lymphomas. A clinicopathologic study. Cancer (1996) 1.40
Management of cancer during pregnancy. Arch Intern Med (1988) 1.32
Pregnancy outcome following cancer chemotherapy. Am J Med (1980) 1.30
Cutaneous melanoma in relation to exogenous hormones and reproductive factors. J Natl Cancer Inst (1983) 1.27
Granulosa cell, Sertoli-Leydig cell, and unclassified sex cord-stromal tumors associated with pregnancy: a clinicopathological analysis of thirty-six cases. Gynecol Oncol (1984) 1.22
Pregnancy and immunity. BMJ (1994) 1.20
Surgery during pregnancy and fetal outcome. Am J Obstet Gynecol (1980) 1.14
Management of breast cancer during pregnancy using a standardized protocol. J Clin Oncol (1999) 1.13
Antineoplastic agents and pregnancy. Semin Oncol (1989) 1.13
Cancer in pregnancy: a review of the literature. Part I. Obstet Gynecol Surv (1996) 1.10
Natural history of cutaneous malignant melanoma. World J Surg (1979) 1.08
Breast cancer during pregnancy. Cancer (1994) 1.06
Carcinoma of the cervix associated with pregnancy. Obstet Gynecol (1982) 1.06
Cutaneous malignant melanoma in women: exogenous sex hormones and reproductive factors. Br J Cancer (1984) 1.05
Ovarian carcinoma during pregnancy: a study of 23 cases in Israel between the years 1960 and 1984. Gynecol Oncol (1989) 1.04
Malignant melanoma arising during pregnancy. A study of 100 patients. Ann Surg (1990) 1.03
Increased thickness of pregnancy-associated melanoma. Br J Dermatol (1995) 1.02
Pelvic masses in pregnancy: MR imaging. Radiology (1990) 1.02
The troublesome concept of the person. Theor Med Bioeth (1999) 0.99
Successful management of Ph chromosome chronic myelogenous leukemia with leukapheresis during pregnancy. Am J Hematol (1991) 0.98
Current management of melanoma. Ann Surg (1977) 0.97
Melanoma and pregnancy. A review. Acta Oncol (1993) 0.96
Lymphoma and pregnancy. Semin Oncol (1989) 0.95
Maternal and foetal outcome following Hodgkin's disease in pregnancy. Br J Cancer (1992) 0.94
Anesthetic risk in the pregnant surgical patient. Anesthesiology (1979) 0.93
Dermatoses of pregnancy. J Am Acad Dermatol (1982) 0.93
Pregnancy and risk of non-Hodgkin's lymphoma: a prospective study. Int J Cancer (1997) 0.93
Long-term follow-up of children born to mothers with acute leukemia during pregnancy. Med Pediatr Oncol (1988) 0.91
Pregnancy and breast cancer. Semin Surg Oncol (1997) 0.90
Prognostic significance of pregnancy in stage I melanoma. Arch Surg (1989) 0.89
Pregnancy and leukemia. Semin Oncol (1989) 0.89
Does pregnancy influence the prognosis of malignant melanoma? J Am Acad Dermatol (1993) 0.88
Recurrent hairy cell leukemia during pregnancy: a case report. Am J Obstet Gynecol (1994) 0.87
Leukemia in pregnancy. Clin Obstet Gynecol (1974) 0.87
The prognosis of cervical cancer associated with pregnancy: a matched cohort study. Obstet Gynecol (1995) 0.87
Pregnancy as a predisposing factor in thyroid neoplasia. Arch Surg (1986) 0.86
Cancer in pregnancy: identification of unanswered questions on maternal and fetal risks. Obstet Gynecol Surv (1990) 0.85
Growth and malignancy of ovarian tumours in pregnancy. Aust N Z J Obstet Gynaecol (1971) 0.84
Pregnancy after high therapeutic doses of iodine-131 in differentiated thyroid cancer: potential risks and recommendations. Eur J Nucl Med (1993) 0.84
Managing hairy cell leukemia in pregnancy. Ann Intern Med (1994) 0.84
When Did I Begin? Conception of the Human Individual in History, Philosophy and Science by Norman M. Ford. Bioethics (1989) 0.84
Association of leukemia and pregnancy: clinical and obstetric aspects. Am J Clin Oncol (1988) 0.83
Breast cancer and pregnancy. Semin Oncol (1989) 0.83
Melanoma during pregnancy. Obstet Gynecol (1969) 0.83
Acute leukemia and pregnancy. Obstet Gynecol Surv (1958) 0.83
Hodgkin's disease and pregnancy. Am J Obstet Gynecol (1952) 0.82
Chemotherapy for metastatic melanoma during pregnancy. Gynecol Oncol (1997) 0.82
Successful pregnancy and delivery during alpha-interferon therapy for chronic myeloid leukemia. Am J Hematol (1992) 0.82
Perinatal ethics: a practical method of analysis of obligations to mother and fetus. Obstet Gynecol (1985) 0.81
Acute leukemia and pregnancy: a review of management and outcome, 1972-1982. Obstet Gynecol Surv (1984) 0.81
Stories and cases: discernment and inference in moral deliberation: Stories and Their Limits: Narrative Approaches to Bioethics, edited by Hilde Lindemann Nelson; and Fragmentation and Consensus: Communitarian and Casuist Bioethics, by Mark G. Kuczewski. Theor Med Bioeth (1999) 0.80
The management of breast carcinoma in pregnancy and lactation. J Surg Oncol (1982) 0.80
Pregnancy and Hodgkin's disease; a report of eight cases. Am J Obstet Gynecol (1953) 0.80
Effects of oral contraceptives and pregnancy on melanomas. N Engl J Med (1979) 0.80
Stage I squamous cell cervical carcinoma in pregnancy: planned delay in therapy awaiting fetal maturity. Gynecol Oncol (1995) 0.80
Breast cancer associated with pregnancy. Obstet Gynecol (1988) 0.79
Acute leukemia during pregnancy: the Toronto Leukemia Study Group experience with long-term follow-up of children exposed in utero to chemotherapeutic agents. J Clin Oncol (1987) 0.79
Hemostatic and fibrinolytic parameters in patients with acute myeloid leukemia: activation of blood coagulation, fibrinolysis and unspecific proteolysis. Blut (1990) 0.79
Treatment of advanced epithelial ovarian carcinoma in pregnancy with cisplatin-based chemotherapy. Gynecol Oncol (1991) 0.78
Massive ovarian tumor complicating pregnancy. A case report. J Reprod Med (1993) 0.78
Rapidly growing thyroid carcinoma during pregnancy. J Surg Oncol (1994) 0.78
Pregnancy after autologous bone marrow transplantation for malignant lymphomas. Nouv Rev Fr Hematol (1994) 0.78
Management of thyroid nodules during pregnancy. Laryngoscope (1995) 0.78
The clinical course of cervical carcinoma in situ diagnosed during pregnancy. Gynecol Oncol (1997) 0.78
[Pregnancy, hormone preparations and malignant melanoma]. Hautarzt (1993) 0.77
Chronic granulocytic leukemia. Review of 536 cases. Arch Intern Med (1976) 0.75
Breast cancer and pregnancy. Obstet Gynecol (1977) 0.75
Hairy cell leukemia in pregnancy: a case report. Am J Obstet Gynecol (1987) 0.75
Gynecologic cancer associated with pregnancy. Semin Oncol (1989) 0.75
Colposcopy in pregnancy. Obstet Gynecol Clin North Am (1993) 0.75
Endocrine tumors and miscellaneous cancers in pregnancy. Semin Oncol (1989) 0.75
Interpretive bioethics: the way of discernment. Theor Med (1990) 0.75
Ovarian cancer associated with pregnancy. Obstet Gynecol (1973) 0.75
Pregnancy and the prognosis of malignant melanoma. Semin Oncol (1996) 0.75
[Fetal risk of cancer chemotherapy (author's transl)]. Bull Cancer (1979) 0.75
All-trans retinoic acid for the treatment of acute promyelocytic leukemia in pregnancy. Obstet Gynecol (1997) 0.75
Carcinoma of the uterine cervix in pregnancy. A study of the incidence and treatment in the western region of Sweden 1973 to 1992. Acta Obstet Gynecol Scand (1997) 0.75
Pregnancy poses tough questions for cancer treatment. J Natl Cancer Inst (1991) 0.75
Fine-needle biopsy of a solitary thyroid nodule arising during pregnancy. J Med Soc N J (1983) 0.75
Chronic granulocytic leukemia in pregnancy. A case report. J Reprod Med (1988) 0.75
The effect of corticosteroid therapy in the very premature infant. March of Dimes Multicenter Study Group. Am J Obstet Gynecol (1994) 0.75
Elective cesarean hysterectomy versus vaginal hysterectomy for the treatment of cervical intraepithelial neoplasia. South Med J (1987) 0.75
[Malignant ovarian tumors in pregnancy]. Harefuah (1990) 0.75
Rituximab therapy of patients with B-cell chronic lymphocytic leukemia. Blood (2001) 2.50
Primary cervical cancer screening by self-sampling of human papillomavirus DNA in internal medicine outpatient clinics. Ann Oncol (2004) 2.20
Fertility after organ-preserving surgery of ectopic pregnancy: results of a multicenter study. Fertil Steril (1997) 2.02
Moderate progress for ovarian cancer in the last 20 years: prolongation of survival, but no improvement in the cure rate. Eur J Cancer (2002) 1.77
Antibodies against the human papillomavirus type 16 early proteins in human sera: correlation of anti-E7 reactivity with cervical cancer. J Natl Cancer Inst (1989) 1.72
Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes (2006) 1.45
[Does the "impact factor" kill the German language?]. Gynakol Geburtshilfliche Rundsch (1997) 1.39
Activation of Src kinases p53/56lyn and p59hck by p210bcr/abl in myeloid cells. Cancer Res (1996) 1.36
Pain intensity following laparoscopy. Surg Laparosc Endosc (1996) 1.26
Screening for cervical neoplasia by self-assessment for human papillomavirus DNA. Lancet (1999) 1.26
Elevated serum thymidine kinase levels identify a subgroup at high risk of disease progression in early, nonsmoldering chronic lymphocytic leukemia. Blood (1999) 1.25
Vaccination of multiple myeloma patients with idiotype-pulsed dendritic cells: immunological and clinical aspects. Br J Haematol (2000) 1.19
Correlation of drug response with the ATP tumorchemosensitivity assay in primary FIGO stage III ovarian cancer. Gynecol Oncol (2000) 1.16
[Radiologic versus ultrasound fallopian tube imaging. Painfulness of the examination and diagnostic reliability of hysterosalpingography and hysterosalpingo-contrast-ultrasonography with echovist 200]. Ultraschall Med (1997) 1.10
The Src family kinase Hck interacts with Bcr-Abl by a kinase-independent mechanism and phosphorylates the Grb2-binding site of Bcr. J Biol Chem (1997) 1.10
Serum beta(2)-microglobulin and serum thymidine kinase are independent predictors of progression-free survival in chronic lymphocytic leukemia and immunocytoma. Leuk Lymphoma (1996) 1.10
Bortezomib retreatment in relapsed multiple myeloma - results from a retrospective multicentre survey in Germany and Switzerland. Oncology (2011) 1.09
[Fetal obstructive uropathy--diagnosis and possible treatments]. Z Geburtshilfe Neonatol (2001) 1.08
[Prenatal diagnosis of kidney parenchyma diseases]. Z Geburtshilfe Neonatol (2001) 1.07
The relationship between monoclonal myeloma precursor B cells in the peripheral blood stem cell harvests and the clinical response of multiple myeloma patients. Br J Haematol (1999) 1.06
Modulation of malignant B cell activation and apoptosis by bcl-2 antisense ODN and immunostimulatory CpG ODN. J Leukoc Biol (2002) 1.06
Psychological implications of infertility in women with polycystic ovary syndrome. Hum Reprod (2008) 1.02
Data quality in computerized patient records. Analysis of a haematology biopsy report database. Int J Clin Monit Comput (1994) 1.02
Attitudes on euthanasia, physician-assisted suicide and terminal sedation--a survey of the members of the German Association for Palliative Medicine. Med Health Care Philos (2004) 1.01
Her-2/neu and urokinase-type plasminogen activator and its inhibitor in breast cancer. Clin Cancer Res (2001) 1.01
Ovarian cancer in elderly patients: carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in late relapse: a Gynecologic Cancer Intergroup (GCIG) CALYPSO sub-study. Ann Oncol (2011) 1.00
Thymidine kinase: a tumor marker with prognostic value for non-Hodgkin's lymphoma and a broad range of potential clinical applications. Ann Hematol (1992) 0.98
Signal transduction of interleukin-6 involves tyrosine phosphorylation of multiple cytosolic proteins and activation of Src-family kinases Fyn, Hck, and Lyn in multiple myeloma cell lines. Exp Hematol (1997) 0.97
Structural aberrations of the Y chromosome and the corresponding phenotype. Report of a case with the karotype 45,X-46,X,i(Yp). Humangenetik (1973) 0.97
In situ amplification of single copy gene segments in individual cells by the polymerase chain reaction. Infection (1991) 0.97
[Ambulatory surgery--changes in surgical gynecology]. Gynakologe (1993) 0.97
[Pregnancy following intrafallopian gamete transfer]. Geburtshilfe Frauenheilkd (1985) 0.96
Cisplatin based chemotherapy in testicular cancer patients: long term platinum excretion and clinical effects. Eur J Med Res (1996) 0.93
Association of urokinase-type plasminogen activator and its inhibitor with disease progression and prognosis in ovarian cancer. Clin Cancer Res (2001) 0.93
[Surgical treatment of ovarian cancer]. MMW Fortschr Med (2005) 0.92
Cellular apoptosis susceptibility gene expression in endometrial carcinoma: correlation with Bcl-2, Bax, and caspase-3 expression and outcome. Int J Gynecol Pathol (2001) 0.92
ETV6-NTRK3 gene fusion in a secretory carcinoma of the breast of a male-to-female transsexual. Breast (2005) 0.91
Prevalence of the metabolic syndrome in German women with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes (2007) 0.90
Immunocytochemical and flow cytometric detection of proteinase 3 (myeloblastin) in normal and leukaemic myeloid cells. Br J Haematol (1995) 0.90
Relationship of queuine-lacking transfer RNA to the grade of malignancy in human leukemias and lymphomas. Cancer Res (1985) 0.89
Interaction of the receptor tyrosine kinase p145c-kit with the p210bcr/abl kinase in myeloid cells. Br J Haematol (1996) 0.89
Evidence for cell adhesion-mediated drug resistance of multiple myeloma cells in vivo. Int J Biol Markers (2006) 0.88
Myomectomy as a pregnancy-preserving option in the carefully selected patient. Fetal Diagn Ther (2002) 0.88
Quantitative 2- and 3-dimensional analysis of pharmacokinetic model-derived variables for breast lesions in dynamic, contrast-enhanced MR mammography. Eur J Radiol (2007) 0.88
Crash emergency cesarean section: decision-to-delivery interval under 30 min and its effect on Apgar and umbilical artery pH. Arch Gynecol Obstet (2005) 0.88
Second malignancies after Hodgkin's disease: the Munich experience. Ann Hematol (1999) 0.87
Fludarabine plus cyclophosphamide is an efficient treatment for advanced chronic lymphocytic leukaemia (CLL): results of a phase II study of the German CLL Study Group. Br J Haematol (2001) 0.87
A CD19-specific single-chain immunotoxin mediates potent apoptosis of B-lineage leukemic cells. Leukemia (2007) 0.87
Hemolytic anemia with pyruvate kinase deficiency presenting as paravertebral myelolipoma. Klin Wochenschr (1984) 0.86
Conservative treatment of endometrial cancer permitting subsequent triplet pregnancy. Gynecol Oncol (1995) 0.86
MR-guided vacuum-assisted breast biopsy with a handheld biopsy system: clinical experience and results in postinterventional MR mammography after 24 h. Eur Radiol (2007) 0.86
Actions of glucagon on flux rates in perfused rat liver. 1. Kinetics of the inhibitory effect on glycolysis and the stimulatory effect on glycogenolysis. Eur J Biochem (1983) 0.85
Parametrial invasion in cervical carcinoma: evaluation of detection at MR imaging with fat suppression. Radiology (1998) 0.85
The anti-idiotypic antibody abagovomab in patients with recurrent ovarian cancer. A phase I trial of the AGO-OVAR. Ann Oncol (2006) 0.84
Conversion of an IGM secreting immunocytoma in a high grade malignant lymphoma of immunoblastic type. Blut (1983) 0.84
[Neoadjuvant therapy of breast cancer]. Gynakol Geburtshilfliche Rundsch (2004) 0.84
Ulcerative colitis in a patient with Wiskott-Aldrich syndrome. Endoscopy (2002) 0.84
Treosulfan as an effective second-line therapy in ovarian cancer. Gynecol Oncol (1998) 0.84
Actions of glucagon on flux rates in perfused rat liver. 2. Relationship between inhibition of glycolysis and stimulation of respiration by glucagon. Eur J Biochem (1983) 0.83
CD30 ligand signal transduction involves activation of a tyrosine kinase and of mitogen-activated protein kinase in a Hodgkin's lymphoma cell line. Cancer Res (1995) 0.83
[Organ-saving surgery of tubal pregnancy]. Geburtshilfe Frauenheilkd (1985) 0.83
Evaluation of quantitative parametric analysis for characterization of breast lesions in contrast-enhanced MR mammography. Eur Radiol (2006) 0.83
Interleukin-6 induces tyrosine phosphorylation of the Ras activating protein Shc, and its complex formation with Grb2 in the human multiple myeloma cell line LP-1. Eur J Immunol (1996) 0.83
Phosphodiesterase type 4 inhibitor suppresses expression of anti-apoptotic members of the Bcl-2 family in B-CLL cells and induces caspase-dependent apoptosis. Leukemia (2001) 0.82
mRNA expression of ligands of the epidermal-growth-factor-receptor in the uterus. Int J Cancer (1997) 0.82
Quantitative determination of the epidermal growth factor receptor in cervical cancer and normal cervical epithelium by 2-color flow cytometry: evidence for down-regulation in cervical cancer. Int J Cancer (1997) 0.82
Drug interactions and cytotoxic effects of paclitaxel in combination with carboplatin, epirubicin, gemcitabine or vinorelbine in breast cancer cell lines and tumor samples. Breast Cancer Res Treat (2001) 0.81
Lymphadenopathy detected by ultrasound examination as first diagnostic hint of chronic lymphocytic leukaemia in a patient with melanoma. J Eur Acad Dermatol Venereol (2002) 0.81
Second-line carboplatin and gemcitabine in platinum sensitive ovarian cancer--a dose-finding study by the Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) Ovarian Cancer Study Group. Ann Oncol (2001) 0.81
Blood stem cell collections after mobilization with combination chemotherapy containing ifosfamide followed by G-CSF in multiple myeloma. Oncology (2003) 0.81
Epidermal-growth-factor receptor correlates negatively with cell density in cervical squamous epithelium and is down-regulated in cancers of the human uterus. Int J Cancer (1998) 0.81
Early detection of maternal risk for preeclampsia. ISRN Obstet Gynecol (2012) 0.81
[Magnetic resonance imaging of the pelvis in patients with polycystic ovary syndrome]. Rofo (2009) 0.81
Obstetric risks and vertical transmission of hepatitis C virus infection in pregnancy. Acta Obstet Gynecol Scand (2000) 0.81
Predictive markers for the FSH sensitivity of women with polycystic ovarian syndrome. Hum Reprod (2014) 0.80
Cap formation on lymphocytes from patients with leukemic diseases induced by four different lectins. Blut (1978) 0.80
Low-dose follicle stimulating hormone for ovulation induction in polycystic ovary syndrome. J Reprod Med (1994) 0.80
Squamous cell carcinoma antigen and carcinoembryonic antigen levels as prognostic factors for the response of cervical carcinoma to chemotherapy. Gynecol Oncol (1990) 0.80
Relationship and prognostic significance of phospho-(serine 166)-murine double minute 2 and Akt activation in node-negative breast cancer with regard to p53 expression. Virchows Arch (2005) 0.80
[LEEP versus cold knife conization for treatment of cervical intraepithelial neoplasias]. Zentralbl Gynakol (2000) 0.80
Signaling defect in the activation of caspase-3 and PKCdelta in human TUR leukemia cells is associated with resistance to apoptosis. Exp Cell Res (1999) 0.80
Morbidity of inguinofemoral lymphadenectomy in vulval cancer. ScientificWorldJournal (2012) 0.80
Photodynamic therapy in women with cervical intraepithelial neoplasia using topically applied 5-aminolevulinic acid. Int J Cancer (1999) 0.80
Helper T cells (CD3 + /CD4 + ) within the autologous peripheral blood stem cell graft positively correlate with event free survival of multiple myeloma patients. Exp Oncol (2008) 0.80
[Quantitative parametric analysis of contrast-enhanced lesions in dynamic MR mammography]. Radiologe (2008) 0.80
[Uterine fibroids--therapy from the point of view of the gynaecologist]. Radiologe (2003) 0.80
The effect of chromomycin and methramycin on the synthesis of deoxyribonucleic acid and ribonucleic acids. Hoppe Seylers Z Physiol Chem (1967) 0.80
The combination of increased ovarian volume and follicle number is associated with more severe hyperandrogenism in German women with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes (2006) 0.79
Changes in clonal growth, immunophenotype, and morphology during a follow-up study of an acute lymphoblastic leukemia. Haematol Blood Transfus (1990) 0.79